Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHSWYICB - Non Consultant Led Community Dermatology Service

NHS West Yorkshire Integrated Care Board

This public procurement record has 1 release in its history.

Award

20 Aug 2026 at 16:30

Award Notice
Summary of the contracting process

NHS West Yorkshire Integrated Care Board is commissioning a non-consultant-led community dermatology service for people in the Wakefield population. The service is a community-based, integrated pathway replacing an existing arrangement, with the population served, geography, referral routes, eligibility criteria, delivery model and contractual outcomes remaining materially unchanged. It covers dermatology services, including activity referred from secondary care pathways, and is delivered in Wakefield. The commissioning body is NHS West Yorkshire Integrated Care Board, which is responsible for the contract. The selected provider, Novus Health Limited, is a Wakefield-based small or medium-sized enterprise. The requirement is for healthcare service providers able to deliver clinically effective community dermatology, work across local referral pathways and maintain continuity for patients while managing demand within the existing service model.

The procurement has reached the award stage: NHS West Yorkshire Integrated Care Board selected Novus Health Limited through Direct Award Process C under the Health Care Services (Provider Selection Regime) Regulations 2023. The award was dated 10 August 2026 and the contract was signed on the same date. The contract period is 1 August 2026 to 31 July 2027, with an awarded and contracted value of £4,665,444 including the stated currency of GBP. The procedure was a limited award without prior publication of a competition. Evaluation used the Provider Selection Regime key criteria, with quality weighted at 100% and cost at 0%, based on narrative service-review evidence. The authority recorded one bid and selected the existing provider because it was judged to meet the service and continuity requirements.

This award indicates established demand for community dermatology in Wakefield, particularly for a provider able to absorb increased referral volumes and elective-recovery activity without changing the underlying service model. A credible competitor for a future requirement would need clinical capability in non-consultant-led dermatology, an established workforce and governance arrangements, and the capacity to deliver a sustained level of patient activity through community pathways. Evidence of safe, effective outcomes and performance against key service measures would be important, alongside cost-effective use of public funds and demonstrable system savings. Strong integration with secondary care, collaborative working across local health services, digital working and service sustainability would support credibility. Providers should also be able to evidence inclusive access, work with underserved populations, social value, local employment and staff wellbeing.

How relevant is this notice?

Notice Information

Notice Title

NHSWYICB - Non Consultant Led Community Dermatology Service

Notice Description

Non-consultant led community dermatology service for the Wakefield population

Lot Information

Lot 1

The Contract Authority; NHS West Yorkshire Integrated Care Board intends to award a contract to an existing provider following Direct Award Process C. The authority is publishing this notice in Find a Tender in accordance with the NHS Provider Selection Regime.

Contract Period: 01/08/2026 - 31/07/2027

Contract Value: PS4,665,444. Additional information: The ICB is not required to follow direct award process A or B
The Record of Decision Making created at the time of the decision confirms that the service:
* is an existing service;
* is delivered by an existing provider - Novus Health Limited;
* is replacing a contract that is due to expire; and
* is therefore eligible in principle for Direct Award Process C.

The commissioner confirms that the proposed contracting arrangements are not changing considerably from the existing contract
The Community Dermatology Service Specification dated 01/08/2026 demonstrates that the proposed contract does not introduce any considerable change when compared with the existing arrangements.
In substance:
* the service model remains a community-based integrated pathway;
* the population, geography, referral routes, and eligibility criteria are unchanged;
* delivery remains with the existing provider, using the same delivery and service model;
* there is no expansion, reconfiguration, or transfer of material risk.
The ICB actively reviewed the proposed scope, duration, outcomes, delivery model, and risk profile against the existing contract and concluded that none of these elements met the PSR "considerable change" threshold. While the specification is presented in an updated format, the underlying service is materially consistent with the existing contract.
The increase in contract value does not arise from any commissioner-led expansion of service scope, specification, patient cohort, eligibility criteria, geography or contractual outcomes. The increase is wholly attributable to unplanned growth in activity driven by external factors, including elective recovery requirements, increased referral volumes and sustained system pressures within secondary care dermatology services. The providers have delivered this additional activity through the existing service model and contractual arrangements. Accordingly, whilst the financial value exceeds the PSR material change threshold, the nature of the service being delivered remains materially unchanged and the increase reflects external demand factors rather than a substantive change to the service commissioned.

Activity by Novus increased from 6,720 attendances in FY21/22 to 14,635 attendances in FY25/26, an increase of approximately 118%. This increase followed system-wide elective recovery requirements and increased referrals from secondary care pathways at Mid Yorkshire Teaching NHS Trust. The increase in contract value reflects actual demand growth and associated activity delivered rather than any expansion of the commissioned service specification.

No changes are proposed to the service specification, referral criteria, population served, service geography, contractual outcomes or delivery model

The ICB is of the view that the existing provider is satisfying the existing contract to a sufficient standard, according to the detail outlined in the contract, and also taking into account the key criteria and applying the basic selection criteria
PSR Key Criteria provides detailed, narrative based evidence demonstrating that the existing provider:
* is satisfying the current contract to a sufficient standard; and
* is likely to satisfy the proposed contract to a sufficient standard.
Commissioners considered whether the increase in contract value, in isolation, should trigger a competitive process. Having reviewed the underlying drivers of demand, commissioners concluded that the increase reflects organic growth in activity within an unchanged service model rather than a change to the commissioned service itself. The essential characteristics of the service remain unchanged.
The Service Review assesses performance against all PSR key criteria, including:
* Quality and innovation - supported by/evidenced by commissioner evaluation of outcomes, policies and procedures against expected standards and KPI's and peer benchmarking.
* Value and stewardship of public funds - demonstrated through cost effectiveness, system savings, sustainability.
* Integration, collaboration, and sustainability - reflected through partnership working, alignment with wider pathways, digital interpolation and investment.
* Access, inequalities, and choice - supported by evidence of targeted interventions, inclusive or adapted provision, reach into underserved or priority populations.
* Social value - including evaluation of local employment and staff wellbeing community capacity building, wider economic or social benefits.
The ICB considered not only historic performance, but also whether the provider's established workforce, governance arrangements, and delivery model provide assurance of continued performance under the proposed contract. The proposed contract does not introduce new delivery requirements, expanded cohorts, or increased demand beyond that already successfully managed by the provider.

Proportionality and Overall Assurance
In determining the appropriate procurement route, the ICB considered whether a competitive process would deliver additional benefit. Given the continuity of need, the absence of material change, the provider's sustained performance, and the risks associated with service disruption, the ICB concluded that a competitive process would not be proportionate to the time, cost, and delivery risk involved.
Taken together, the three documents; Record of Decision Making, Service Specification and Service Review Template provide a coherent and auditable justification for the use of Direct Award Process C. WY ICB remains satisfied that the requirements of the Provider Selection Regime have been properly applied.

Procurement Information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the Standstill Period. Representations by providers must be made to the relevant authority by 1 September 2026. This contract has not yet formally been awarded; this notice serves as an intention to award a contract under the PSR.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06e904
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/079636-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services

CPV Codes

85121282 - Dermatology services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£4,665,444 £1M-£10M

Notice Dates

Publication Date
20 Aug 20266 days ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
10 Aug 20262 weeks ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS West Yorkshire Integrated Care Board
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BRADFORD
Postcode
BD1 4AS
Postcode Area
Bradford
Country
England
Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE41 Bradford
Delivery Location
TLE45 Wakefield
Local Authority
Bradford
Electoral Ward
City
Westminster Constituency
Bradford West

Supplier Information

Number of Suppliers
1
Supplier Name

Novus Health Limited

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...